Onconetix (ONCO) Revenue (2024 - 2026)

Onconetix (ONCO) has reported Revenue for 3 consecutive years, with $17120.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue fell 83.92% year-over-year to $17120.0 in Q2 2026; TTM through Jun 2026 was $645824.0, a 51.33% decrease from a year earlier, with the FY2025 full-year figure at $815371.0, down 67.7% from the prior year.
• Revenue was $17120.0 for Q2 2026 at Onconetix, down from $21457.0 in the prior quarter.
• Over five years, Revenue peaked at $711976.0 in Q4 2024 and troughed at $17120.0 in Q2 2026.
• A 3-year average of $337806.4 and a median of $303623.5 in 2025 frame the typical range for Revenue.
• The widest YoY moves for Revenue: up 25.37% in 2025, down 85.49% in 2025.
• Over 3 years, Revenue stood at $711976.0 in 2024, then slumped by 57.36% to $303596.0 in 2025, then slumped by 94.36% to $17120.0 in 2026.
• The last three Revenue figures came in at $17120.0 (Q2 2026), $21457.0 (Q1 2026), and $303596.0 (Q4 2025), per Business Quant data.